Skip to main content
COVID-19 treatment: Cipla launches generic version of remdesivir ‘Cipremi’ at Rs 4,000 per vial - Times Now 10-Jul-2020
COVID-19 treatment: Cipla launches generic version of remdesivir ‘Cipremi’ at Rs 4,000 per vial - Times Now
Cipla's cipremi has been approved by the Drug Controller General of India for restricted emergency use in the country as part of the accelerated approval process considering the urgent and unmet medical need.
More...